MyFinsight

HomeBlogAboutContact

MyFinsight

Making company financials insightful for everyone

Quick Links

  • About
  • Blog
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

For the quarter ending 2026-03-31, SNDX made $64,864K in revenue. -$42,673K in net income. Net profit margin of -65.79%.

Income Overview

Revenue
$64,864K
Net Income
-$42,673K
Net Profit Margin
-65.79%
EPS
-$0.48
Unit: Thousand (K) dollars
Revenue Breakdown
    • Product
    • Collaboration Revenue

Income Statement
2026-03-31
2025-12-31
2025-09-30
2025-06-30
Total revenues
64,864 88,523 45,871 37,958
Cost of product sales
2,633 1,902* 2,100 1,279
Research and development
58,845 186,328* 56,280 62,227
Selling, general and administrative
37,588 46,599* 44,917 43,805
Collaboration loss
0 ---
Total operating expenses
99,066 234,828 103,297 107,311
Loss from operations
-34,202 -146,305 -57,426 -69,353
Royalty interest expense
11,846 11,999* 8,283 7,854
Other expense
---586
Other interest expense
0 0* 0 4
Interest income
3,561 5,902* 5,269 5,950
Other expense
-186 -458* -275 -
Total other (expense) income, net
-8,471 -6,555 -3,289 -2,494
Net loss
-42,673 -152,860 -60,715 -71,847
Basic EPS
-0.48 -1.75 -0.7 -0.83
Diluted EPS
-0.48 -1.75 -0.7 -0.83
Basic Average Shares
88,255,636 87,372,322 86,620,992 86,337,237
Diluted Average Shares
88,255,636 87,372,322 86,620,992 86,337,237
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.

Time Plot

Show the time plot by selecting a row from the table.

Income Statement

DownloadDownload image
Net loss-$42,673K Product$48,923K Collaboration Revenue$15,941K Loss from operations-$34,202K Total other (expense)income, net-$8,471K Total revenues$64,864K Interest income$3,561K Total operatingexpenses$99,066K Royalty interestexpense$11,846K Other expense-$186K Research and development$58,845K Selling, general andadministrative$37,588K Cost of product sales$2,633K

Syndax Pharmaceuticals Inc (SNDX)

Syndax Pharmaceuticals Inc (SNDX)